BRD4-BD1-IN-1

• UNSPSC Description:

  BRD4-BD1-IN-1 (Compound 9a) is a BRD4-BD1 inhibitor with an IC50 of 38.20 μM[1].

• Target Antigen:

  Epigenetic Reader Domain

• Type:

  Reference compound

• Related Pathways:

  Epigenetics

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/brd4-bd1-in-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(OCC1=NC2=C(N1CC3=CC(Br)=CC=C3)C(NC(N2C)=O)=O)=O

• Molecular Weight:

  407.22

• References & Citations:

  [1]Chang Y, et al. Design, synthesis, biological evaluation, and molecular docking of 1, 7-dibenzyl-substituted theophylline derivatives as novel BRD4-BD1-selective inhibitors. Medicinal Chemistry Research, 2021, 30(8): 1453-1468.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2761321-18-8